Therapeutic Drug Monitoring in the Long-Term Care Facility

Stevens MR . In service: Pharmacokinetics. Gerigram 1985; 178: 2–3.

Beller GA Smith TW Abelmann WH Haber E Wood WB . Digitalis intoxication. N Engl J Med 1971; 284: 989–97.

Rodensky PL Wasserman F Gables C . Observations on digitalis intoxication. Arch Intern Med 1961; 108: 171–88.

Jelliffe RW Buell J Kalaba R . Reduction of digitalis toxicity by computer-assigned glycoside dosage regimens. Ann Intern Med 1972; 77: 891–906.

Ogilvie RI Ruedy J . Adverse drug reactions during hospitalization. Can Med Assoc J 1967; 97: 1450–7.

Ogilvie RI Ruedy J . An educational program in digitalis therapy. JAMA 1972; 222: 50–5.

Zwillich CW Sutton FD Neff TA Cohn WM Matthay RA Weinberger MM . Theophylline-induced seizure in adults: Correlation with serum concentrations. Ann Intern Med 1975; 82: 784–7.

Hendeles L Bighley L Richardson RH Hepler CD Carmichael J . Frequent toxicity from IV aminophylline infusions in critically ill patients. Drug Intell Clin Pharm 1977; 11: 12–8.

Cohen IS Jick H Cohen SI . Adverse reactions to quinidine in hospitalized patients: Findings based on data from the Boston Collaborative Drug Surveillance Program. Prog Cardiovasc Dis 1977; 20: 151–63.

Dalby MA . Behavioral effects of carbamazepine. In: Penry JK Daly DD , eds. Complex partial seizures and their treatment. New York: Raven Press, 1975:331–44.

Reynolds EH . Chronic antiepileptic toxicity: A review. Epilepsia 1975; 16: 319–52.

Podrid PH Schoeneberger A Lown B . Congestive heart failure caused by oral disopyramide. N Engl J Med 1980; 302: 614–7.

Desai JM Scheinman MM Hirschfeld D Gonzales R Peters RW . Cardiovascular collapse associated with disopyramide therapy. Chest 1981; 79: 545–51.

Adams PC Campbell RWF Julian DG . The clinical pharmacology of antiarrhythmic drugs. In: Conti CR , ed. Cardiac drug therapy. Philadelphia: FA Davis, 1984:153–90.

Smith TW Antman EM Friedman PL Blatt CM Marsh JD . Digitalis glycosides: Mechanisms and manifestations of toxicity. Prog Cardiovasc Dis 1984; 27: 21–56.

Ghadrian AM Lehmann HE . Neurological side effects of lithium: Organic brain syndrome, seizures, extrapyramidal side effects, and EEG changes. Compr Psychiatry 1980; 21: 327–35.

Caird FI Scott PJW . Drug-induced diseases in the elderly. New York: Elsevier, 1978.

Moorman JR . Digitalis toxicity at Duke Hospital 1973 to 1984. South Med J 1985; 78: 561–4.

Moorman JR Pritchett ELC . The arrhythmias of digitalis intoxication. Arch Intern Med 1985; 145: 1289–92.

Podrid PJ . Aggravation of ventricular arrhythmia. A drug-induced complication. Drugs 1985; 29 (suppl 4): 33–44.

Velebit V Podrid P Lown B Cohen BH Graboys TB . Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 1982; 65: 886–94.

Stilman N Masdeu JC . Incidence of seizures with phenytoin toxicity. Neurology 1985; 35: 1769–72.

Snead OC Hosey LC . Exacerbation of seizures in children by carbamazepine. N Engl J Med 1985; 313: 916–21.

Troupin AS Ojemann LM . Paradoxical intoxication—a complication of anticonvulsant administration. Epilepsia 1975; 16: 753–8.

Levine JH Guarnieri T Michael JR . Multifocal atrial tachycardia: A toxic effect of theophylline. Lancet 1985; 1: 12–4.

Marchlinski FE Miller JM . Atrial arrhythmias exacerbated by theophylline. Response to verapamil and evidence for triggered activity in man. Chest 1985; 88: 931–4.

Koch-Weser J Duhme DW Greenblatt DJ . Influence of serum digoxin concentration measurements on frequency of digitoxicity. Clin Pharmacol Ther 1972; 16: 284–7.

Duhme DW Greenblatt DJ Koch-Weser J . Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program. Ann Intern Med 1974; 80: 516–9.

Schapel GJ Jones TE Draysey TC . The predictive value of the serum digoxin concentration in the management of hospitalized patients. Ther Drug Monit 1981; 3: 137–42.

Levy G . Applied pharmacokinetics—a prospectus. In: Evans WE Schentag JJ Jusko WJ , eds. Applied pharmacokinetics. Principles of therapeutic drug monitoring. 2nd ed. San Francisco: Applied Therapeutics, 1986:xxi–xxiv.

Azarnoff DL . Application of blood level data of clinical trials. Clin Pharmacol Ther 1974; 16: 183–8.

Brodie BB . Physicochemical and biochemical aspects of pharmacology. JAMA 1967; 202: 600–9.

Koch-Weser J . Serum drug concentrations as therapeutic guides. N Engl J Med 1972; 287: 227–31.

Fox J Hicks P Feldman BR Davis WJ Feldman CH . Theophylline blood levels as a guide to intravenous therapy in children. Am J Dis Child 1982; 136: 928–30.

Mungall DF Marshall J Penn D Robinson A . Individualizing theophylline therapy: The impact of clinical pharmacokinetics on patient outcomes. Ther Drug Monit 1983; 5: 95–101.

Reynolds EH Chadwick D Galbraith AW . One drug (phenytoin) in the treatment of epilepsy. Lancet 1976; 1: 923–6.

Shorvon SD Chadwick D Galbraith AW Reynolds EH . One drug for epilepsy. Br Med J 1978; 1: 474–6.

Irvine RE Grove J Toseland PA Trounce JR . The effect of age on hydroxylation of amylobarbitone sodium in man. Br J Clin Pharmacol 1974; 1: 41–3.

Ochs HR Greenblatt DJ Woo E Smith TW . Reduced quinidine clearance in elderly persons. Am J Cardiol 1978; 42: 481–5.

Drayer DE Hughes M Lorenzo B Reidenberg MM . Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum and clearance of quinidine in cardiac patients with age. Clin Pharmacol Ther 1980; 27: 72–5.

Jusko WJ Gardner MJ Mangione A Schentag JJ Koup JR Vance JW . Factors affecting theophylline clearance: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates and ethanol. J Pharm Sci 1979; 68: 1358–66.

Antal EJ Kramer PA Mercik SA Chapron DJ Lowson IR . Theophylline pharmacokinetics in advanced age. Br J Clin Pharmacol 1981; 12: 637–45.

Rowe JW Andres R Tobin JD Norris AH Shock NW . The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol 1976; 31: 155–63.

Davies DF Shock NW . Age changes in glomerular filtration rate, effective renal plasma flow and tubular excretory capacity in adult males. J Clin Invest 1950; 29: 496–507.

Wilkens CE Khurana MS . Digitalis withdrawal in elderly nursing home patients. J Am Geriatr Soc 1985; 33: 850–1.

Johnston GD McDevitt DC . Is maintenance digoxin necessary in patients with sinus rhythm? Lancet 1979; 1: 567–70.

Liverpool Therapeutics Group. Use of digitalis in general practice. Br Med J 1978; 2: 673–5.

Bethell HJN . Discontinuation of maintenance digoxin (letter). Lancet 1977; 2: 1186.

Hull SM Mackintoch A . Discontinuation of maintenance digoxin therapy in general practice. Lancet 1977; 2: 1054–5.

Fleg JL Gottlieb SH Lakatta EG . Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm. Am J Med 1982; 73: 244–50.

Dall JLC . Maintenance digoxin in elderly patients. Br Med J 1970; 2: 705–6.

Dobbs SA Kenyon WI Dobbs RJ . Maintenance digoxin after an episode of heart failure: Placebo-controlled trial in outpatients. Br Med J 1977; 1: 749–52.

Krakauer R Peterson B . The effects of discontinuing maintenance digoxin therapy; a study of elderly cardiac patients in sinus rhythm. Dan Med Bull 1979; 26: 10–3.

Boman K . Digoxin and the geriatric in-patient. Acta Med Scand 1983; 214: 353–60.

Eaton ML MacDonald FM Church TR Niewoehner DE . Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction. Chest 1982; 82: 538–42.

Eaton ML Green BA Church TR McGowan T . Efficacy of theophylline in “irreversible” airflow obstruction. Ann Intern Med 1980; 92: 758–61.

Alexander MR Dull WL Kasik JE . Treatment of chronic obstructive pulmonary disease with orally administered theophylline: A double-blind, controlled study. JAMA 1980; 244: 2286–90.

Jenne JW Siever JR Druz WS Solano JV . The effect of maintenance theophylline therapy on lung work in severe chronic obstructive pulmonary disease while standing and walking. Am Rev Respir Dis 1984; 130: 600–5.

Mahler DA Matthey RA Snyder PE Wells CK . Sustained-release theophylline reduces dyspnea in non-reversible obstructive airway disease. Am Rev Respir Dis 1985; 131: 22–5.

Chadwick D Reynolds EH . When do epileptic patients need treatment? Starting and stopping medication. Br Med J 1985; 290: 1885–8.

Delgado-Escueta AV Treiman DM Walsh GO . The treatable epilepsies (second of two parts). N Engl J Med 1983; 308: 1576–84.

Browne TR Feldman RG . Epilepsy. Diagnosis and management. Boston: Little, Brown: 1983:156–60.

Pratt CM Delelos G Wierman AM . The changing base line of complex ventricular arrhythmias. A new consideration in assessing long-term antiarrhythmic drug therapy. N Engl J Med 1985; 313: 1444–9.

Kanamycin and neomycin—deafness—legal action. Clin-Alert 1977; Nov 1: 192.

Gentamicin—renal failure—nerve damage—legal action. Clin-Alert 1979; Dec 31: 263.

Gentamicin—renal failure—legal action. Clin-Alert 1979; Dec 31: 264.

Lidocaine—brain damage—quadraplegia—legal action. Clin-Alert 1982; Nov 26: 242.

Tobramycin—legal action. Clin-Alert 1981; Dec 11: 242.